SELUTION SLR SUSTANE
AssetAlso SUSTANE DEB
Drug-eluting balloon delivering sirolimus to maintain arterial patency in peripheral artery intervention
- Stage
- Phase 3
- Modality
- Device
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Superficial femoral artery disease
Phase 3, businesswire.com, 6 Oct 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.